Renaissance Technologies »

Foghorn Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-09-30 $235k 25k 9.31
2024-06-30 $62k 11k 5.75

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
Novo-nordisk A S Adr (NVO)
United Therapeutics Corporation (UTHR)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Verisign (VRSN)
Sprouts Fmrs Mkt (SFM)
Airbnb Com Cl A (ABNB)
NVIDIA Corporation (NVDA)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Fortinet (FTNT)
Meta Platforms Cl A (META)

View all positions for Renaissance Technologies

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
BVF
Deerfield Management Company
Raymond James & Associates
BlackRock
Euclidean Capital
BlackRock
Vanguard Group
Siren
Geode Capital Management
Alphabet
State Street Corporation
Point72 Asset Management
Birchview Capital
Northern Trust

View all funds holding Foghorn Therapeutics